Clot-busting treatment for a second stroke within 24 hours
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a clot-busting medicine given through a vein can help people who have had a stroke in the last 3 months and are now having another stroke. The goal is to see if this treatment is safe and improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently having a stroke or woke up with stroke symptoms within the last 24 hours.
- You have had a previous stroke in the last 3 months.
- You are 18 years old or older.
- You are not planning to have a clot-removal procedure (endovascular treatment).
- You do not have conditions that increase bleeding risk, such as recent bleeding, surgery, or certain blood-thinning medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This trial tests whether a clot-busting drug given through a vein can safely and effectively treat strokes in people who also have active cancer. It aims to see if this treatment can improve recovery without increasing bleeding risks.
This trial tests whether a stronger clot-busting drug (tenecteplase) is safe and works for people who have had a stroke while taking a common blood thinner. If you qualify, you may get this treatment within a few hours of your stroke to help improve recovery.
This study tracks people who get a clot-busting medicine for a stroke more than 4.5 hours after symptoms start. It aims to see if this type of treatment is safe and helpful for patients who arrive later, such as after sleeping.
This trial tests giving a second dose of an IV clot-dissolving medicine (prourokinase) to patients who had a stroke from a large clot but didn't improve enough after the first dose. The goal is to see if a second dose within 6 hours of stroke onset can help more patients recover.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.